Citation APA
Maertens, J., Aoun, M., Baddley, J. J., Giladi, M., Heinz, W. W., Herbrecht, R., Hope, W., Karthaus, M., Lee, D. G., Lortholary, O., Morrison, V. A., Raad, I. I., Oren, I., Selleslag, D., Shoham, S., Thompson, G. R., Lee, M., Maher, R. R., Schmitt-Hoffmann, A. H., Zeiher, B., Ullmann, A., Marr, K. K., Patterson, T. F., Kontoyiannis, D. D., Cornely, O. A., Bow, E. J., Rahav, G., & Neofytos, D. (2016). Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial. Lancet, 387(10020), 760-769. doi:10.1016/S0140-6736(15)01159-9
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231579